Latest stories on COGT
VGTel, Inc. (OTC: VGTL) Announces Creative OS Commercialization Strategy and Technology Infrastructure Expansion
GlobeNewswire54 · neutralproduct/pr
VGTel, Inc. (OTC: VGTL) Announces Creative OS Commercialization Strategy and Technology Infrastructure Expansion
StockTitan54 · neutralproduct/pr
Cogent Biosciences added to Analyst Focus List at JPMorgan
The Fly63 · neutralanalyst
Bank of America Scrambles to Refinance Internet Provider Cogent
Bloomberg48 · neutralgeneral
Cogent Biosciences, Inc. (COGT) files 8-K
SEC 8-K50 · neutralgeneral
Cogent Biosciences: 3 NDAs Create A Time-To-Market Moat
Seeking Alpha67 · bullishproduct/pr
Cogent’s Q2 results broadly in line with expectations, says H.C. Wainwright
The Fly56 · neutralearnings
Cogent downgraded to Underweight from Neutral at JPMorgan
The Fly38 · neutralanalyst
Cogent price target lowered to $11 from $17 at UBS
The Fly34 · bearishanalyst
Cogent Biosciences price target raised to $55 from $52 at Piper Sandler
The Fly61 · neutralanalyst
Cogent price target lowered to $12 from $18 at RBC Capital
The Fly33 · bearishanalyst
Cogent price target lowered to $11 from $17 at UBS
The Fly34 · bearishanalyst
Guggenheim raises Cogent stock price target to $52 on FDA decisions
Investing.com Analyst Ratings61 · neutralanalyst
Cogent Biosciences Announces $400 Million ATM Offering
TipRanks28 · bearishgeneral
Cogent Biosciences, Inc. (COGT) files 8-K
SEC 8-K50 · neutralgeneral
Cogent Biosciences Achieves Key Milestones with Bezuclastinib, Maintains Strong Cash Position Through 2028
August 10, 2026
MarketChameleon73 · bullishproduct/pr
Cogent Biosciences reports Q2 results
Seeking Alpha50 · neutralearnings
Cogent Biosciences, Inc. (COGT) files 8-K
SEC 8-K50 · neutralgeneral
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2026 Financial Results
Business Insider73 · bullishproduct/pr
Cogent price target lowered to $12 from $16 at Goldman Sachs
The Fly34 · bearishanalyst
Cogent price target lowered to $30 from $34 at TD Cowen
The Fly38 · neutralanalyst
Cogent Price Target Lowered To 15 From 25 At Keybanc
The Fly34 · bearishanalyst
Cogent Unveils VR-1, the First Mythos-Class Frontier AI Model Trained Specifically to Excel at Cybersecurity Tasks
PR Newswire73 · bullishproduct/pr
Cogent Bioscience (COGT) Files New Drug Application For Bezuclastinib
Yahoo Finance73 · bullishproduct/pr